Agminated melanocytic nevus status post dabrafenib therapy for metastatic melanoma.
暂无分享,去创建一个
[1] A. Menzies,et al. Cutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors for Metastatic Melanoma. , 2015, JAMA dermatology.
[2] K. Flaherty,et al. Melanocytic nevi excised during B-Raf proto-oncogene (BRAF) inhibitor therapy: A study of 19 lesions from 10 patients. , 2015, Journal of the American Academy of Dermatology.
[3] S. Swetter,et al. Involution of eruptive melanocytic nevi on combination BRAF and MEK inhibitor therapy. , 2014, JAMA dermatology.
[4] H. Gollnick,et al. High incidence of naevi-associated BRAF wild-type melanoma and dysplastic naevi under treatment with the class I BRAF inhibitor vemurafenib. , 2014, Acta dermato-venereologica.
[5] Hei Sung Kim,et al. Agminated Acquired Melanocytic Nevi of the Common and Dysplastic Type , 2013, Annals of dermatology.
[6] Y. Yoshida,et al. Acquired agminated melanocytic naevi: report of two cases and review of the literature. , 2012, Acta dermato-venereologica.
[7] A. Hauschild,et al. Atypical melanocytic proliferations and new primary melanomas in patients with advanced melanoma undergoing selective BRAF inhibition. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.